Evidence map›Paper›PMID 29869169›Full record

ArticleMolecular diversity2018

Synthesis and biological evaluation of novel flavone/triazole/benzimidazole hybrids and flavone/isoxazole-annulated heterocycles as antiproliferative and antimycobacterial agents.

Yerrabelly Jayaprakash Rao, Thummala Sowjanya, Gogula Thirupathi, Nandula Yadagiri Sreenivasa Murthy, Sudha Sravanti Kotapalli

Abstract read
PubMed Publisher
In one paragraph

Article in Molecular diversity, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Review
  2. Review
  3. Review
  4. Review
  5. Article
  6. Review
  7. Review
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Yerrabelly Jayaprakash RaoDepartment of Chemistry, University College of Science, Saifabad, Osmania University, Hyderabad, India. yjpr_19@yahoo.com.
Thummala SowjanyaDepartment of Chemistry, Jawaharlal Nehru Technological University, Hyderabad, India.
Gogula ThirupathiDepartment of Chemistry, University College of Science, Saifabad, Osmania University, Hyderabad, India.
Nandula Yadagiri Sreenivasa MurthyDepartment of Chemistry, Palamuru University, Mahabubnagar, India.
Sudha Sravanti KotapalliCentre for Chemical Biology, Indian Institute of Chemical Technology, Hyderabad, India.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A series of new flavone/isoxazole fused heterocycles 5a-f and flavone/1,2,3-triazole/benzimidazole hybrid heterocycles compounds 7a-t were synthesized via an intramolecular cyclization and Cu(I)-catalyzed click 1,3-dipolar cycloaddition. The products were evaluated for their antiproliferative activity against human breast cancer cell line (MCF-7) using sulforhodamine B assay (SRB) and antimycobacterial activity using turbidometric assay. The majority of the tested compounds exhibited antiproliferative activity and antimycobacterial activity. Compounds 7l, 7q and 7r showed moderate antiproliferative activity with IC50 values 17.9, 14.2, 19.1 [Formula: see text], respectively, and compound 5a showed moderate antimycobacterial activity with 41.7% of inhibition at 30 [Formula: see text] concentration.

Indexed as

Anti-Bacterial AgentsAntineoplastic AgentsBenzimidazolesCell ProliferationChemistry Techniques, SyntheticFlavonesHumansInhibitory Concentration 50IsoxazolesMCF-7 CellsMicrobial Sensitivity TestsTriazolesAnti-Bacterial AgentsAntineoplastic AgentsBenzimidazolesFlavonesIsoxazolesTriazoles1, 2, 3-Triazole8-Formyl-7-hydroxy flavonesAntimycobacterial activityAntiproliferative activityClick chemistryCycloaddition

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.